Drug Trial Radar · NCT03069352
A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy
Last checked: Nov 20, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
211
Actual
Start
May 29, 2017
Primary completion
Feb 15, 2019
Study completion Aug 21, 2025
Sponsor
- Lead sponsor
- AbbVieAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Mar 3, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate if venetoclax when co administered with low-dose cytarabine (LDAC) improves overall survival (OS) versus LDAC and placebo, in treatment-naïve patients with acute myeloid leukemia (AML).
Conditions
- Acute Myeloid Leukemia (AML)
Interventions
PlaceboDrug
tablet
VenetoclaxDrug
tablet
CytarabineDrug
Subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival (OS)Time frame: From randomization until the primary analysis cut-off date of February 15 2019; the median follow-up time was 12.0 months (range: 0.2-17.0) in the placebo arm and 12.0 months (range: 0.1-17.6) in the venetoclax arm.
Locations
109 sites in 24 countries. Site status is shown where the registry gives one.
H. Lee Moffit Cancer Center /ID# 164273
Tampa, Florida
Norton Cancer Institute /ID# 158998
Louisville, Kentucky
Univ of Pittsburgh Med Ctr /ID# 158997
Pittsburgh, Pennsylvania
Univ TX, MD Anderson /ID# 159678
Houston, Texas
Swedish Medical Center /ID# 161280
Seattle, Washington
Gundersen Health System /ID# 164272
La Crosse, Wisconsin
Cemic /Id# 159676
Buenos Aires, Argentina
Sanatorio Allende /ID# 159675
Córdoba, Argentina
Calvary Mater Newcastle /ID# 160123
Waratah, New South Wales, Australia
Westmead Hospital /ID# 160121
Westmead, New South Wales, Australia
Alfred Hospital /ID# 160125
Melbourne, Victoria, Australia
Box Hill Hospital /ID# 162920
Melbourne, Victoria, Australia
Universitair Ziekenhuis Antwerpen /ID# 159566
Edegem, Antwerpen, Belgium
Cliniques Universitaires Saint Luc /ID# 159567
Woluwe-Saint-Lambert, Brussels Capital, Belgium
Hospital do Cancer Mae de Deus /ID# 163416
Porto Alegre, Brazil
Centro de Pesquisas Oncologicas /ID# 163567
Florianópolis, Santa Catarina, Brazil
Hospital de Cancer de Barretos /ID# 163568
Barretos, São Paulo, Brazil
Casa de Saúde Santa Marcelina /ID# 163413
São Paulo, São Paulo, Brazil
University of Alberta Hospital /ID# 159646
Edmonton, Alberta, Canada
CISSS de la Monteregie /ID# 159782
Greenfield Park, Quebec, Canada
Hospital Maisonneuve-Rosemont /ID# 159780
Montreal, Quebec, Canada
Hopital Sacre Coeur Montreal /ID# 160982
Montreal, Quebec, Canada
Qilu Hospital of Shandong Univ /ID# 167507
Jinan, China
Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 167515
Wuhan, China
Henan Cancer Hospital /ID# 167327
Zhengzhou, Henan, China
Fujian Medical Univ Union Hosp /ID# 167321
Fuzhou, Fujian, China
Nanfang Hospital of Southern Medical University /ID# 170147
Guangzhou, Guangdong, China
Jiangsu Province People's Hospital /ID# 167511
Nanjing, Jiangsu, China
The First Hosp of Jilin Univ /ID# 167512
Changchun, Jilin, China
Ruijin Hospital, Shanghai Jiaotong /ID# 167325
Shanghai, Shanghai Municipality, China
West China Hospital /ID# 167514
Chengdu, Sichuan, China
Blood disease hosp of Chinese Academy of Med Sciences(Institute of Hematology) /ID# 167509
Tianjin, Tianjin Municipality, China
The First Affiliated Hospital,College of Medicine, Zhejiang University /ID# 167324
Hangzhou, Zhejiang, China
Fakultni Nemocnice Brno /ID# 159247
Brno, Czechia
Univ Hosp Ostrava-Poruba /ID# 159246
Ostrava, Czechia
Fakult Nem Kralovske Vinohrady /ID# 159248
Prague, Czechia
Centre Hospitalier de la Cote /ID# 159697
Bayonne, France
CHU Bordeaux /ID# 159704
Pessac, France
CHU De Nancy /ID# 159700
Vandœuvre-lès-Nancy, France
Centre Hospitalier Lyon Sud /ID# 159705
Pierre-Bénite, Rhone, France
Showing 40 of 109 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.